These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 30384323)

  • 21. Commonality of Ethanol and Nicotine Reinforcement and Relapse in Wistar-Derived UChB Rats: Inhibition by N-Acetylcysteine.
    Quintanilla ME; Morales P; Ezquer F; Ezquer M; Herrera-Marschitz M; Israel Y
    Alcohol Clin Exp Res; 2018 Oct; 42(10):1988-1999. PubMed ID: 30035805
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The delta 2-opioid receptor antagonist naltriben reduces motivated responding for ethanol.
    June HL; McCane SR; Zink RW; Portoghese PS; Li TK; Froehlich JC
    Psychopharmacology (Berl); 1999 Nov; 147(1):81-9. PubMed ID: 10591872
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nicotine Enhances the Hypnotic and Hypothermic Effects of Alcohol in the Mouse.
    Slater CA; Jackson A; Muldoon PP; Dawson A; O'Brien M; Soll LG; Abdullah R; Carroll FI; Tapper AR; Miles MF; Banks ML; Bettinger JC; Damaj IM
    Alcohol Clin Exp Res; 2016 Jan; 40(1):62-72. PubMed ID: 26727524
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combined varenicline and naltrexone treatment reduces smoking topography intensity in heavy-drinking smokers.
    Roche DJ; Bujarski S; Hartwell E; Green R; Ray LA
    Pharmacol Biochem Behav; 2015 Jul; 134():92-8. PubMed ID: 25933795
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Varenicline, a partial agonist at neuronal nicotinic acetylcholine receptors, reduces nicotine-induced increases in 20% ethanol operant self-administration in Sprague-Dawley rats.
    Bito-Onon JJ; Simms JA; Chatterjee S; Holgate J; Bartlett SE
    Addict Biol; 2011 Jul; 16(3):440-9. PubMed ID: 21392178
    [TBL] [Abstract][Full Text] [Related]  

  • 26. α6β2 nicotinic acetylcholine receptors influence locomotor activity and ethanol consumption.
    Kamens HM; Peck C; Garrity C; Gechlik A; Jenkins BC; Rajan A
    Alcohol; 2017 Jun; 61():43-49. PubMed ID: 28457669
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of adolescent alcohol exposure via oral gavage on adult alcohol drinking and co-use of alcohol and nicotine in Sprague Dawley rats.
    Chandler CM; Hamid U; Maggio SE; Peng H; Pauly JR; Beckmann J; Nixon K; Bardo MT
    Drug Alcohol Depend; 2022 Mar; 232():109298. PubMed ID: 35038606
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of Varenicline on Neural Correlates of Alcohol Salience in Heavy Drinkers.
    Vatsalya V; Gowin JL; Schwandt ML; Momenan R; Coe MA; Cooke ME; Hommer DW; Bartlett S; Heilig M; Ramchandani VA
    Int J Neuropsychopharmacol; 2015 Jul; 18(12):. PubMed ID: 26209857
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, selectively decreases ethanol consumption and seeking.
    Steensland P; Simms JA; Holgate J; Richards JK; Bartlett SE
    Proc Natl Acad Sci U S A; 2007 Jul; 104(30):12518-23. PubMed ID: 17626178
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The opioid receptor antagonist nalmefene reduces responding maintained by ethanol presentation: preclinical studies in ethanol-preferring and outbred Wistar rats.
    June HL; Grey C; Warren-Reese C; Durr LF; Ricks-Cord A; Johnson A; McCane S; Williams LS; Mason D; Cummings R; Lawrence A
    Alcohol Clin Exp Res; 1998 Dec; 22(9):2174-85. PubMed ID: 9884166
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of ceftriaxone on ethanol, nicotine or sucrose intake by alcohol-preferring (P) rats and its association with GLT-1 expression.
    Sari Y; Toalston JE; Rao PSS; Bell RL
    Neuroscience; 2016 Jun; 326():117-125. PubMed ID: 27060486
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of sazetidine-A, a selective alpha4beta2 nicotinic acetylcholine receptor desensitizing agent on alcohol and nicotine self-administration in selectively bred alcohol-preferring (P) rats.
    Rezvani AH; Slade S; Wells C; Petro A; Lumeng L; Li TK; Xiao Y; Brown ML; Paige MA; McDowell BE; Rose JE; Kellar KJ; Levin ED
    Psychopharmacology (Berl); 2010 Aug; 211(2):161-74. PubMed ID: 20535453
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of Drinking Risk Levels as Outcomes in Alcohol Pharmacotherapy Trials: A Secondary Analysis of 3 Randomized Clinical Trials.
    Falk DE; O'Malley SS; Witkiewitz K; Anton RF; Litten RZ; Slater M; Kranzler HR; Mann KF; Hasin DS; Johnson B; Meulien D; Ryan M; Fertig J;
    JAMA Psychiatry; 2019 Apr; 76(4):374-381. PubMed ID: 30865232
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relative potency of varenicline or fluvoxamine to reduce responding for ethanol versus food depends on the presence or absence of concurrently earned food.
    Ginsburg BC; Lamb RJ
    Alcohol Clin Exp Res; 2014 Mar; 38(3):860-70. PubMed ID: 25396255
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combined varenicline and naltrexone attenuates alcohol cue-elicited activation in heavy drinking smokers.
    Grodin EN; Burnette EM; Green R; Lim AC; Miotto K; Ray LA
    Drug Alcohol Depend; 2021 Aug; 225():108825. PubMed ID: 34175784
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oral operant ethanol self-administration in the absence of explicit cues, food restriction, water restriction and ethanol fading in C57BL/6J mice.
    Stafford AM; Anderson SM; Shelton KL; Brunzell DH
    Psychopharmacology (Berl); 2015 Oct; 232(20):3783-95. PubMed ID: 26268145
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacotherapy for Substance Use Disorders.
    Klein JW
    Med Clin North Am; 2016 Jul; 100(4):891-910. PubMed ID: 27235620
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of a novel alcohol and nicotine concurrent access (ANCA) self-administration procedure in baboons.
    Holtyn AF; Davis CM; Weerts EM
    Drug Alcohol Depend; 2020 Jan; 206():107665. PubMed ID: 31801108
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Co-administration of ethanol and nicotine: the enduring alterations in the rewarding properties of nicotine and glutamate activity within the mesocorticolimbic system of female alcohol-preferring (P) rats.
    Deehan GA; Hauser SR; Waeiss RA; Knight CP; Toalston JE; Truitt WA; McBride WJ; Rodd ZA
    Psychopharmacology (Berl); 2015 Dec; 232(23):4293-302. PubMed ID: 26306917
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhanced alcohol-seeking behavior by nicotine in the posterior ventral tegmental area of female alcohol-preferring (P) rats: modulation by serotonin-3 and nicotinic cholinergic receptors.
    Hauser SR; Deehan GA; Toalston JE; Bell RL; McBride WJ; Rodd ZA
    Psychopharmacology (Berl); 2014 Sep; 231(18):3745-55. PubMed ID: 24599396
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.